Chenliang Pan
Overview
Explore the profile of Chenliang Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei J, Lu A, Pan C, Wang L, Ma J, Bai N, et al.
Perfusion
. 2024 Nov;
:2676591241300946.
PMID: 39547655
Background: In recent years, during the decannulation process for veno-arterial extracorporeal membrane oxygenation (VA-ECMO), methods for suturing the femoral artery have included the pre- and post-closure techniques. The safety and...
2.
Xiao H, Pu J, Jiang G, Pan C, Xu J, Zhang B, et al.
J Cardiothorac Surg
. 2024 Jun;
19(1):341.
PMID: 38907341
Background: Long non-coding RNAs (lncRNAs) are abundant and closely related to the occurrence and development of human diseases. LncRNAs are known to play a key role in many cardiovascular diseases....
3.
Lv X, Wu X, Liu K, Zhao X, Pan C, Zhao J, et al.
Cancer Innov
. 2023 Dec;
2(5):391-404.
PMID: 38090380
Background: Patients frequently die from cardiac causes after radiotherapy for esophageal cancer. Early detection of cardiac death risk in these patients is crucial to improve clinical decision-making and prognosis. Thus,...
4.
Li N, Pan C, Lu G, Pan H, Han Y, Wang K, et al.
Adv Mater
. 2023 Dec;
36(5):e2311023.
PMID: 38050947
Electrocatalytic synthesis of amino acids provides a promising green and efficient pathway to manufacture the basic substances of life. Herein, reaction of 2,5-perfluroalkyl-terepthalohydrazide and tris(4-µ -O-carboxaldehyde-pyrazolato-N, N')-tricopper affords a crystalline...
5.
Lv X, Wu X, Liu K, Zhao X, Pan C, Zhao J, et al.
Cardiovasc Toxicol
. 2023 Oct;
23(11-12):377-387.
PMID: 37804372
The primary cause of mortality in esophageal cancer survivors is cardiac death. Early identification of cardiac mortality risk during chemotherapy for esophageal cancer is crucial for improving the prognosis. We...
6.
Gao H, Bai M, Chu A, Pan C, Zhao J, Zhang Z, et al.
J Med Life
. 2023 Jul;
16(5):719-724.
PMID: 37520492
This retrospective study aimed to evaluate the safety and efficacy of continuous renal replacement therapy (CRRT) during percutaneous coronary intervention (PCI) in patients with severe acute myocardial infarction (AMI). The...
7.
Lv X, Pan C, Guo H, Chang J, Gao X, Wu X, et al.
ESC Heart Fail
. 2023 May;
10(4):2170-2182.
PMID: 37170474
Early diagnosis of cancer treatment-related cardiac dysfunction (CTRCD) is important as cancer therapy increases the risk of cardiac dysfunction. High-sensitivity cardiac troponin T (hs-cTnT) is a highly specific marker of...
8.
Pan C, Zhao J, Zhang B, Lu A, Bai M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
. 2022 Dec;
34(10):1031-1035.
PMID: 36473559
Objective: To investigate the effect of extracorporeal membrane oxygenation (ECMO) on in-hospital survival and prognosis of adult patients with fulminant myocarditis. Methods: The registration materials of 21 patients with fulminant...
9.
Hu S, Lu A, Pan C, Zhang B, Wa Y, Qu W, et al.
Front Med (Lausanne)
. 2022 Aug;
9:938634.
PMID: 35911410
Background: This study aimed to summarize and analyse the risk factors, clinical features, as well as prevention and treatment of limb ischemia complications in patients on veno-arterial extracorporeal membrane oxygenation...
10.
Bai M, Lu A, Pan C, Hu S, Qu W, Zhao J, et al.
Front Med (Lausanne)
. 2022 Jun;
9:913403.
PMID: 35692539
Background: The safety and feasibility of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as mechanical circulatory support in high-risk percutaneous coronary intervention (HR-PCI) remain unclear. Methods: This retrospective study included patients with...